Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Advanced Drainage Systems Inc (WMS) Price & Performance

Heron Therapeutics IncTrade
Advanced Drainage Systems IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Advanced Drainage Systems Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Advanced Drainage Systems Inc trades at $125.56 (market cap $9.51B). The key difference: Advanced Drainage Systems Inc is far larger — about 128.4× Heron Therapeutics Inc's market cap, and Advanced Drainage Systems Inc pays a 0.63% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Advanced Drainage Systems Inc for 43 Days on average.

HRTXWMS
Market Cap
$74.04M$9.51B
Volume
3,668,095771,064
Sector
HealthBasic Materials
52-Week High
$1.49$175.38
52-Week Low
$0.27$125.33
Typical Hold Time
35 Days43 Days
Enterprise Value
$180.78M$11.11B
Dividend Yield
—0.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.

The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.

Advanced Drainage Systems Inc

Advanced Drainage Systems (WMS) trades at $126.21, down 2.97% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news includes the release of its 2026 Sustainability Report and a quarterly dividend declaration.

The outlook is mixed; analyst consensus targets $188.70, implying significant upside, but near-term technical pressure and a projected net cash outflow in 2026 present risks. Investment appeal hinges on execution of growth initiatives and margin stability against macroeconomic and competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
WMS
100% Buy0% Sell
Avg holding period · 43 Days

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Advanced Drainage Systems Inc

Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe

Read more on WMS →